PNEUMOCYSTIS JIROVECII PNEUMONIA IN NON-HIV PATIENTS

Clinical trials for PNEUMOCYSTIS JIROVECII PNEUMONIA IN NON-HIV PATIENTS explained in plain language.

Never miss a new study

Get alerted when new PNEUMOCYSTIS JIROVECII PNEUMONIA IN NON-HIV PATIENTS trials appear

Sign up with your email to follow new studies for PNEUMOCYSTIS JIROVECII PNEUMONIA IN NON-HIV PATIENTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Could a lower dose of a common antibiotic be safer and just as effective for a deadly pneumonia?

Disease control Not yet recruiting

This study looks at whether a lower dose of the antibiotic TMP-SMX works as well as the standard dose for treating a serious lung infection called Pneumocystis pneumonia (PCP) in people who do not have HIV. The standard dose often causes side effects in more than half of patients…

Matched conditions: PNEUMOCYSTIS JIROVECII PNEUMONIA IN NON-HIV PATIENTS

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control

Last updated Jul 16, 2026 00:00 UTC

PNEUMOCYSTIS JIROVECII PNEUMONIA IN NON-HIV PATIENTS

Get alerted when new PNEUMOCYSTIS JIROVECII PNEUMONIA IN NON-HIV PATIENTS trials appear

Could a lower dose of a common antibiotic be safer and just as effective for a deadly pneumonia?